Compass Therapeutics, Inc. announced that Stephen Squinto, Ph.D., a member of the Board of Directors, notified the Company of his resignation from the Board and all committees thereof, effective August 31, 2022. Dr. Squinto has been a member of the Board since 2015, when he joined representing an early investor in the Company and he is now moving on to pursue other professional endeavors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.05 USD | +3.96% | +21.25% | -32.69% |
Jul. 01 | Compass Therapeutics, Inc.(NasdaqCM:CMPX) dropped from Russell 2000 Growth Index | CI |
Jul. 01 | Compass Therapeutics, Inc.(NasdaqCM:CMPX) dropped from Russell Microcap Growth Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.69% | 139M | |
+20.17% | 127B | |
+24.67% | 117B | |
+25.44% | 27.67B | |
-17.74% | 20.33B | |
-15.17% | 16.79B | |
-15.21% | 15.63B | |
+11.91% | 14.84B | |
-47.10% | 14.65B | |
+54.50% | 14.43B |
- Stock Market
- Equities
- CMPX Stock
- News Compass Therapeutics, Inc.
- Compass Therapeutics, Inc. Announces Resignation of Stephen Squinto as Member of the Board of Directors, Effective August 31, 2022